one.bio

the biopharmaceutical industry currently contributes $750b to a very large, growing and transforming healthcare market. today the majority of biopharm assets are sourced externally rather than developed “in-house”. the life science transactions market place is fragmented and inefficient. the value chain is vast and complex. scientific, financial, legal, marketing, and operational resources need to interact in a systematic fashion for there to be effective decision making. the challenge starts with identification of the right people and companies, and subsequent funneling of potential opportunities into the vetting process toward filling a need for a new product or therapy. one.bio created meet.bio a simple to use web platform that brings together the core ingredients of the life science transaction space; people, assets and locations. it enables professionals in this dynamic ecosystem to find, connect, and interact with business partners in order to streamline the transaction process.